Xinxiang, China

Guojie Fan

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Henan Zhiwei Biomedicine Co., Ltd.. Active years: 2025.


% Patents Active = 100.0


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guojie Fan: Innovator in Biomedicine

Introduction

Guojie Fan is a prominent inventor based in Xinxiang, China. He has made significant contributions to the field of biomedicine, particularly in the development of novel compounds for therapeutic applications. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Guojie Fan holds a patent for a compound titled "Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors." This patent discloses a compound of formula I or a pharmaceutically acceptable salt, active metabolite, tautomer, stereoisomer, or prodrug thereof as BTK (Bruton's Tyrosine Kinase) inhibitors. This compound is particularly useful for the treatment of autoimmune diseases, inflammatory diseases, cancer, and potentially allergies. He has 1 patent to his name.

Career Highlights

Guojie Fan is associated with Henan Zhiwei Biomedicine Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biomedicine sector, contributing to the understanding and treatment of various diseases.

Collaborations

Guojie Fan collaborates with notable colleagues, including Minghao Zhao and Qingyun Li. Their combined expertise enhances the research and development initiatives at their company.

Conclusion

Guojie Fan's innovative work in biomedicine exemplifies the impact of research on health solutions. His contributions, particularly in the area of Bruton's tyrosine kinase inhibitors, highlight the importance of continued innovation in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…